Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma

Sasaki, R; Fukushima, M; Haraguchi, M; Honda, T; Miuma, S; Miyaaki, H; Nakao, K

Sasaki, R (通讯作者)，Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan.

MEDICINE, 2022; 101 (19):

Abstract

Anti-VEGF drugs, such as tyrosine kinase inhibitors, play an important role in systemic therapy for unresectable hepatocellular carcinoma (uHCC). We e......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索